跳至主要内容
临床试验/NCT03358303
NCT03358303进行中(未招募)不适用

Effect of a Mobile Phone-based Telemonitoring Program on the Outcome of Heart Failure Patients After an Incidence of Acute Decompensation

University Health Network, Toronto6 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2018年11月16日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
90
试验地点
6
主要终点
Change in NYHA class

研究概览

简要总结

Heart failure is the most rapidly rising cardiovascular disease and has come to be recognized as a growing epidemic. Digital health interventions are the most recent iteration of an effort to promote individualized outpatient care through positive behaviour change theory. The UHN team has developed a highly automated and user-centered smartphone-based system, Medly, which allows for the telemonitoring of patients diagnosed with heart failure. The purpose of this study will be two-fold: 1) to determine if the introduction of Medly within two weeks of discharge will improve self-care management, quality of life, and clinical status, 2) to assess whether Medly will lead to a potential reduction in 30 day readmission rates amongst HF patients in the Toronto Central Local Health Integration Network (TC LHIN), without increasing the average length of stay or visits to the emergency department. These parameters will be measured as secondary outcomes.

详细描述

Heart failure is the most rapidly rising cardiovascular disease and has come to be recognized as a growing epidemic. Digital health interventions are the most recent iteration of an effort to promote individualized outpatient care through positive behaviour change theory. The UHN team has developed a highly automated and user-centered smartphone-based system, Medly, which allows for the telemonitoring of patients diagnosed with heart failure

Patients with heart failure will be provided with a smartphone and commercial home medical devices, such as a blood pressure monitor and weight scale. The measurements from the medical devices will be automatically sent to the smartphone, and from there to a data server at the hospital for analysis and storage. Both clinicians and patients will be able to access these data and will be sent alerts by the system if the measurements are outside of the normal range. The system will be evaluated through interviews and comparing outcomes between the intervention and control groups.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults (18 years or older)
  • Hospitalization for decompensated HF > 48 hours
  • Patient speaks and reads English adequately to provide informed consent and understand the text prompts in the application (or has an informal caregiver who can translate for them)
  • Ability to comply with using Medly (ex. able to stand on the weight scale, able to answer symptom questions, etc.)

排除标准

  • Dementia or uncontrolled psychiatric illness
  • Residents of long-term care facilities
  • Terminal diagnosis of any health condition with a life expectancy < 1 year
  • Patients who will require inpatient rehabilitation after discharge
  • Participating in another clinical trial that may confound the results

研究组 & 干预措施

Control

No Intervention

Standard of care: Control groups will receive standard medical care when discharged from hospital, including discharge instructions, home medications as well as follow-up in a heart failure clinic or with a primary care doctor.

Telemonitoring (Medly)

Experimental

Medly is a smartphone application allows heart failure (HF) patients to measure and record their daily weight, blood pressure (BP), heart rate, and self-reported symptoms. This monitoring information is then transmitted wirelessly to a data server where an algorithm is used to generate an alert to a healthcare provider as necessary. The patient also receives an automated self-care message based on their measurements and reported symptoms.

干预措施: Medly (Device)

结局指标

主要结局

Change in NYHA class

时间窗: Baseline, 1 month, 3 months

Change in NYHA class

Compliance with Medly utilization

时间窗: 3 months

Ability to adhere to Medly program

Change in quality of life

时间窗: Baseline, 3 months

Change in quality of life, as measured with the Kansas City Cardiomyopathy Questionnaire (KCCQ-12) and EuroQol (EQ5D)

Change in self-care of health failure

时间窗: Baseline, 3 months

Change in self-care of health failure as measured by the Self-Care of Heart Failure Index (SCHFI)

Change BNP/NT-pro BNP levels

时间窗: Baseline, 1 month, 3 months

Change BNP/NT-pro BNP levels

次要结局

  • Hospital length of stay(0 - 3 months)
  • 30-day HF readmission rate(1 month, 3 months)
  • Number of visits to the emergency department(0 - 3 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验